Your search for ‘Winston & Strawn’ returned 436 results

The urgency of the crisis has forced policymakers and regulators to rethink long-established practices and develop innovative solutions.

In December 2022, the Modernization of Cosmetics Regulation Act (MoCRA) directed the FDA to conduct research into the effects of PFAS use in cosmetics.

In June 2021, the Food and Drug Administration (FDA or the Agency) issued draft guidance (Guidance) to assist supply chain stakeholders, particularly trading partners...

Winston & Strawn's Women in Antitrust limited podcast series continues with a new episode focusing on the world of sports. Partner and host Diana Leiden pitches some curve balls to two other...

Addressing the Challenges of Employee Student Loan Debt.

The US Supreme Court's unanimous decision in Slack Technologies v. Pirani holds that under Section 11 of the Securities Act of 1933, plaintiffs must plead...

This article was originally published in Bloomberg Law. Any opinions in this article are not those of Winston & Strawn or its clients. The opinions in this article are the authors' opinions only.

The U.S. Department of Commerce, through its Bureau of Industry and Security (BIS), continues to actively pursue investigations under Section 232 of the Trade Expansion Act of 1962.

Regulatory uncertainty has haunted the digital asset space since its inception. The U.S. Securities and Exchange Commission (SEC) and the Commodity Futures Trading Commission (CFTC)...

In this two-part episode of Let's Talk Lending, Winston & Strawn Partner Alan Hoffman is joined by guest speaker Zach Effron, an Executive Director at JPMorgan focused on global stadium and arena financings.

Earlier this month, the Food and Drug Administration (FDA or the Agency) issued guidance (Guidance) to aid trading partners (manufacturers, repackagers, wholesale distributors, and dispensers)...

The SEC previously provided guidance regarding digital assets in various speeches,[1] reports,[2] and no-action letters.

During this episode of Winston & Strawn's Benefits Blast Podcast, Employee Benefits attorneys David Rogers and Ruth Wimer...

In a unanimous decision issued May 18, 2023, the Supreme Court found that certain claims of Amgen Inc.'s patents for PCSK9-inhibiting antibodies are too broad to enable a claim...

On October 16, 2024, the New York Department of Financial Services (DFS) released an important industry guidance letter aimed at addressing the novel, complex cybersecurity risks associated...

There have been some important changes since 1 January 2021. However, some important matters do not change as a result of Brexit and the TCA.

On March 1, 2022, Judge Albright denied Defendant Apple, Inc.'s ("Apple") Motion to Transfer Venue to the Northern District of California ("NDCA"), "alleging that it is more convenient than this District."